Literature DB >> 21777821

CSF α-synuclein, tau, and amyloid β in Parkinson's disease.

Min Shi, Jing Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21777821     DOI： 10.1016/S1474-4422(11)70130-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  8 in total

1.  CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.

Authors:  Changqin Liu; Brenna Cholerton; Min Shi; Carmen Ginghina; Kevin C Cain; Peggy Auinger; Jing Zhang
Journal:  Parkinsonism Relat Disord       Date:  2015-01-05       Impact factor: 4.891

2.  Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers.

Authors:  J O Aasly; M Shi; V Sossi; T Stewart; K K Johansen; Z K Wszolek; R J Uitti; K Hasegawa; T Yokoyama; C P Zabetian; H M Kim; J B Leverenz; C Ginghina; J Armaly; K L Edwards; K W Snapinn; A J Stoessl; J Zhang
Journal:  Neurology       Date:  2011-12-14       Impact factor: 9.910

3.  Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease.

Authors:  Catherine Pan; Ané Korff; Douglas Galasko; Carmen Ginghina; Elaine Peskind; Ge Li; Joseph Quinn; Thomas J Montine; Kevin Cain; Min Shi; Jing Zhang
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.

Authors:  Jing Zhang; Hayley A Mattison; Changqin Liu; Carmen Ginghina; Peggy Auinger; Michael P McDermott; Tessandra Stewart; Un Jung Kang; Kevin C Cain; Min Shi
Journal:  Acta Neuropathol       Date:  2013-05-04       Impact factor: 17.088

Review 5.  Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?

Authors:  Carla M Lema Tomé; Trevor Tyson; Nolwen L Rey; Stefan Grathwohl; Markus Britschgi; Patrik Brundin
Journal:  Mol Neurobiol       Date:  2012-04-29       Impact factor: 5.590

6.  A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy.

Authors:  Christina D Orrù; Thong C Ma; Andrew G Hughson; Bradley R Groveman; Ankit Srivastava; Douglas Galasko; Rachel Angers; Patrick Downey; Karen Crawford; Samantha J Hutten; Un Jung Kang; Byron Caughey
Journal:  Ann Clin Transl Neurol       Date:  2020-12-29       Impact factor: 4.511

Review 7.  Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Authors:  Oddvar Myhre; Hans Utkilen; Nur Duale; Gunnar Brunborg; Tim Hofer
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

Review 8.  Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.

Authors:  Nadia Magdalinou; Andrew J Lees; Henrik Zetterberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-01       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.